Press Releases Orexo AB OTC Markets

Equities

ORXOY

US68616W1027

Market Closed - OTC Markets Other stock markets 07:30:30 06/05/2024 pm IST			5-day change	1st Jan Change
1.65 ^USD	+17.86%		0.00%	+9.27%

08/05	Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024
17/04	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm	10/05	AQ
Orexo Q1 2024 Interim Report	08/05	AQ
Fentanyl awareness day: The synthetic opioid fentanyl increasingly poisons young Americans	07/05	PU
Orexo : Invitation to presentation of Orexo´s Q1 2024 Interim Report	02/05	PU
Report from Orexo AB's annual general meeting, 26 April 2024	26/04	AQ
Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US	17/04	AQ
Orexo announces that the condition for early redemption of its existing bonds has been fulfilled	02/04	AQ
Orexo publishes the Annual and Sustainability Report for 2023	28/03	AQ
Correction: Notice of Annual General Meeting of Orexo	15/03	AQ
Notice of Annual General Meeting of Orexo	15/03	AQ
Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds	14/03	AQ
Orexo contemplates issuance of senior secured callable floating rate social bonds and announces a conditional tender offer for its existing bonds	08/03	AQ
Orexo strengthens its sustainability work by establishing a social financing framework	08/03	AQ
Orexo and Sobi agree to advance feasibility study with AmorphOX	12/02	AQ
Orexo Interim Report Q4 2023, incl. Full Year Report	08/02	AQ
Orexo's OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC	06/02	AQ
Orexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose	28/11	AQ
Orexo Q3 2023 Interim Report	02/11	AQ
Orexo announces changes in the company's Board of Directors	30/23/30	AQ
Orexo announces changes in the company's Board of Directors	27/23/27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Orexo AB OTC Markets

Equities

ORXOY

US68616W1027

Press Releases

Filters